Pharmx Technologies Limited (ASX:PHX)
Australia · Delayed Price · Currency is AUD 0.0820
-0.0040 (-4.65%)
Sep 9, 2026, 2:53 PM AEST
Pharmx Technologies Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 7.62 | 7.32 | 6.49 | 6.13 | 5.39 | |
Revenue Growth | 4.06% | 12.84% | 5.88% | 13.78% | -54.65% |
Cost of Revenue | 5.64 | 5.4 | 4.13 | 4.12 | 3.25 |
Gross Profit | 1.98 | 1.92 | 2.36 | 2.01 | 2.14 |
Selling, General & Admin | 1.3 | 0.8 | 2.64 | 1.7 | 1.15 |
Research & Development | -0.33 | -0.32 | -0.14 | -0.09 | -0.1 |
Other Operating Expenses | 0.05 | 0.04 | - | - | 0.09 |
Operating Expenses | 3.74 | 2.02 | 3.72 | 2.67 | 2.01 |
Operating Income | -1.76 | -0.1 | -1.36 | -0.67 | 0.13 |
Interest Expense | -0.04 | -0.03 | -0.04 | -0.05 | -0.01 |
Interest & Investment Income | 0.12 | 0.21 | 0.29 | - | - |
Other Non Operating Income (Expenses) | - | - | 1.31 | - | - |
EBT Excluding Unusual Items | -1.69 | 0.08 | 0.2 | -0.72 | 0.12 |
Pretax Income | -1.69 | 0.08 | 0.2 | -0.72 | 0.12 |
Income Tax Expense | 0.14 | 0.34 | 0.11 | 0.16 | 0.25 |
Earnings From Continuing Operations | -1.83 | -0.26 | 0.1 | -0.88 | -0.13 |
Earnings From Discontinued Operations | - | - | -1.86 | -0.17 | 0.38 |
Net Income | -1.83 | -0.26 | -1.77 | -1.05 | 0.25 |
Net Income to Common | -1.83 | -0.26 | -1.77 | -1.05 | 0.25 |
Net Income Growth | - | - | - | - | -76.90% |
Shares Outstanding (Basic) | 620 | 599 | 598 | 597 | 597 |
Shares Outstanding (Diluted) | 620 | 599 | 598 | 597 | 601 |
Shares Change | 3.58% | 0.06% | 0.17% | -0.56% | 9.81% |
EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
EPS Growth | - | - | - | - | -78.89% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 0.81 | -8.16 | 3.19 | 10.86 | 3.19 |
Free Cash Flow Per Share | 0.00 | -0.01 | 0.01 | 0.02 | 0.01 |
Gross Margin | 25.99% | 26.17% | 36.33% | 32.72% | 39.74% |
Operating Margin | -23.15% | -1.37% | -21.01% | -10.85% | 2.36% |
Profit Margin | -23.97% | -3.61% | -27.27% | -17.15% | 4.68% |
Free Cash Flow Margin | 10.57% | -111.49% | 49.16% | 177.23% | 59.15% |
EBITDA | -1.75 | -0.09 | -1.08 | -0.22 | 0.68 |
EBITDA Margin | -22.95% | -1.20% | -16.60% | -3.57% | 12.61% |
D&A For EBITDA | 0.02 | 0.01 | 0.29 | 0.45 | 0.55 |
EBIT | -1.76 | -0.1 | -1.36 | -0.67 | 0.13 |
EBIT Margin | -23.14% | -1.37% | -21.01% | -10.85% | 2.36% |
Effective Tax Rate | - | 434.18% | 52.74% | - | 207.38% |
Revenue as Reported | 7.74 | 7.53 | - | - | - |